Get startedLog in
    Picture of Vanda Pharmaceuticals logo

    VNDA — Vanda Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    All News

    Brief: Drugmaker Vanda Announces Bysanti NDA Filing

    Picture of Vanda Pharmaceuticals logoVanda Pharmaceuticals
    05/05/2025 13:36
    May 5 (Reuters) - Vanda Pharmaceuticals Inc VNDA.O:

VANDA ANNOUNCES BYSANTI™ NDA FILING; FDA DECISION EXPECTED IN EARLY 2026

VANDA PHARMACEUTICALS INC - FDA DECISION ON BYSANTI NDA EXPECTED BY FEBRUARY 21, 2026

VANDA PHARMACEUTICALS INC - BYSANTI ELIGIBLE FOR 5-YEAR REGULATORY DATA EXCLUSIVITY IF APPROVED

Source text: ID:nPn435b7ta

Further company coverage: VNDA.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Vanda Pharmaceuticals

    See all news